Drug and Alcohol Testing

Drug and Alcohol Testing

February 05, 2024

The recent "Day with DISA 2024" session, titled "Clearinghouse & DOT: Updates from the Top" presented by Bryan Price, Chief of Drug & Alcohol Policy and Compliance, and Stacy Johnson, Federal Program Specialist, provided invaluable insights for HR professionals into the latest updates and statistics related to drug and alcohol testing in the motor carrier industry. Led by experts from the Federal Motor Carrier Safety Administration (FMCSA), the session delved into the Clearinghouse's operational impacts, recent enhancements based on industry feedback, and detailed statistics.

Drug and Alcohol Testing

December 11, 2023

As of January 1, 2024, California will introduce the AB 2188 update. This legislative update significantly alters the landscape for employers, shaping how they approach hiring, termination, and other critical employment decisions based on cannabis use. Jennifer Mora, Senior Counsel at Seyfarth Shaw LLP, presented a webinar for DISA Global Solutions to address these updates. Join us as we discuss the details of AB 2188, unravel its core provisions, explore exceptions, and address the considerable challenges it poses for employers navigating California’s evolving legal framework.

Drug and Alcohol Testing

December 08, 2023

As of January 1, 2024, California will introduce the AB 2188 update. This legislative update significantly alters the landscape for employers, shaping how they approach hiring, termination, and other critical employment decisions based on cannabis use. Jennifer Mora, Senior Counsel at Seyfarth Shaw LLP, recently discussed these updates in a recent webinar presentation for DISA, followed by a Q&A session offering further insights into the intricacies of AB 2188 and the challenges it presents for employers navigating California’s evolving legal framework. Here are some of the most commonly asked questions regarding AB 2188.

Drug and Alcohol Testing

November 10, 2023

On November 7, 2023, Ohio voters passed Ohio Issue 2, Marijuana Legalization Initiative (Issue 2), legalizing recreational cannabis in the state. Issue 2 is a voter initiative, meaning that the legislature may still choose to adjust or, in rare cases, even repeal the initiative.

Drug and Alcohol Testing

November 09, 2023

The world of illicit drugs has seen a shift largely driven by the emergence of fentanyl. Allen Johnson, VP of Marketing, Psychemedics, recently presented a webinar for DISA covering the essential information about fentanyl followed by Q&A with attendees. Here are some of the most common questions Allen sees on the topic.

Drug and Alcohol Testing

November 03, 2023

The world of illicit drugs has seen a shift largely driven by the emergence of fentanyl. This blog will guide you through the myths and truths surrounding fentanyl and testing methods that will appropriately find fentanyl. Allen Johnson, VP of Marketing, Psychemedics, recently presented a webinar for DISA covering the essential and need-to-know information about fentanyl.  Here’s a summary of everything he discussed.

Drug and Alcohol Testing

October 24, 2023

On October 12, 2023, the Substance Abuse and Mental Health Services Administration (SAMHSA) announced updates to the Mandatory Guidelines for Federal Workplace Drug Testing Programs using Urine (UrMG) and the Mandatory Guidelines for Federal Workplace Drug Testing Programs using Oral Fluid (OFMG) via the Federal Register. Each document received a number of updates, including updates to how the annual drug testing panel is published, revisions to definitions, information on an authorized biomarker testing panel, updates to collection procedures, revisions to the Medical Review Officer (MRO) process, and more.